A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target

The identification of new drug targets is highly challenging, particularly for diseases of the brain. This study describes a general computational gene regulatory framework called CRAFT for drug target discovery, and the authors use CRAFT to identify the microglial membrane receptor Csf1R as a poten...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Prashant K. Srivastava, Jonathan van Eyll, Patrice Godard, Manuela Mazzuferi, Andree Delahaye-Duriez, Juliette Van Steenwinckel, Pierre Gressens, Benedicte Danis, Catherine Vandenplas, Patrik Foerch, Karine Leclercq, Georges Mairet-Coello, Alvaro Cardenas, Frederic Vanclef, Liisi Laaniste, Isabelle Niespodziany, James Keaney, Julien Gasser, Gaelle Gillet, Kirill Shkura, Seon-Ah Chong, Jacques Behmoaras, Irena Kadiu, Enrico Petretto, Rafal M. Kaminski, Michael R. Johnson
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Q
Acceso en línea:https://doaj.org/article/c0cffc3635504945bbe2f39f8175da2f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c0cffc3635504945bbe2f39f8175da2f
record_format dspace
spelling oai:doaj.org-article:c0cffc3635504945bbe2f39f8175da2f2021-12-02T17:31:16ZA systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target10.1038/s41467-018-06008-42041-1723https://doaj.org/article/c0cffc3635504945bbe2f39f8175da2f2018-09-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-06008-4https://doaj.org/toc/2041-1723The identification of new drug targets is highly challenging, particularly for diseases of the brain. This study describes a general computational gene regulatory framework called CRAFT for drug target discovery, and the authors use CRAFT to identify the microglial membrane receptor Csf1R as a potential therapeutic target for epilepsy.Prashant K. SrivastavaJonathan van EyllPatrice GodardManuela MazzuferiAndree Delahaye-DuriezJuliette Van SteenwinckelPierre GressensBenedicte DanisCatherine VandenplasPatrik FoerchKarine LeclercqGeorges Mairet-CoelloAlvaro CardenasFrederic VanclefLiisi LaanisteIsabelle NiespodzianyJames KeaneyJulien GasserGaelle GilletKirill ShkuraSeon-Ah ChongJacques BehmoarasIrena KadiuEnrico PetrettoRafal M. KaminskiMichael R. JohnsonNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-15 (2018)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Prashant K. Srivastava
Jonathan van Eyll
Patrice Godard
Manuela Mazzuferi
Andree Delahaye-Duriez
Juliette Van Steenwinckel
Pierre Gressens
Benedicte Danis
Catherine Vandenplas
Patrik Foerch
Karine Leclercq
Georges Mairet-Coello
Alvaro Cardenas
Frederic Vanclef
Liisi Laaniste
Isabelle Niespodziany
James Keaney
Julien Gasser
Gaelle Gillet
Kirill Shkura
Seon-Ah Chong
Jacques Behmoaras
Irena Kadiu
Enrico Petretto
Rafal M. Kaminski
Michael R. Johnson
A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target
description The identification of new drug targets is highly challenging, particularly for diseases of the brain. This study describes a general computational gene regulatory framework called CRAFT for drug target discovery, and the authors use CRAFT to identify the microglial membrane receptor Csf1R as a potential therapeutic target for epilepsy.
format article
author Prashant K. Srivastava
Jonathan van Eyll
Patrice Godard
Manuela Mazzuferi
Andree Delahaye-Duriez
Juliette Van Steenwinckel
Pierre Gressens
Benedicte Danis
Catherine Vandenplas
Patrik Foerch
Karine Leclercq
Georges Mairet-Coello
Alvaro Cardenas
Frederic Vanclef
Liisi Laaniste
Isabelle Niespodziany
James Keaney
Julien Gasser
Gaelle Gillet
Kirill Shkura
Seon-Ah Chong
Jacques Behmoaras
Irena Kadiu
Enrico Petretto
Rafal M. Kaminski
Michael R. Johnson
author_facet Prashant K. Srivastava
Jonathan van Eyll
Patrice Godard
Manuela Mazzuferi
Andree Delahaye-Duriez
Juliette Van Steenwinckel
Pierre Gressens
Benedicte Danis
Catherine Vandenplas
Patrik Foerch
Karine Leclercq
Georges Mairet-Coello
Alvaro Cardenas
Frederic Vanclef
Liisi Laaniste
Isabelle Niespodziany
James Keaney
Julien Gasser
Gaelle Gillet
Kirill Shkura
Seon-Ah Chong
Jacques Behmoaras
Irena Kadiu
Enrico Petretto
Rafal M. Kaminski
Michael R. Johnson
author_sort Prashant K. Srivastava
title A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target
title_short A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target
title_full A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target
title_fullStr A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target
title_full_unstemmed A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target
title_sort systems-level framework for drug discovery identifies csf1r as an anti-epileptic drug target
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/c0cffc3635504945bbe2f39f8175da2f
work_keys_str_mv AT prashantksrivastava asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT jonathanvaneyll asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT patricegodard asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT manuelamazzuferi asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT andreedelahayeduriez asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT juliettevansteenwinckel asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT pierregressens asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT benedictedanis asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT catherinevandenplas asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT patrikfoerch asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT karineleclercq asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT georgesmairetcoello asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT alvarocardenas asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT fredericvanclef asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT liisilaaniste asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT isabelleniespodziany asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT jameskeaney asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT juliengasser asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT gaellegillet asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT kirillshkura asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT seonahchong asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT jacquesbehmoaras asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT irenakadiu asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT enricopetretto asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT rafalmkaminski asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT michaelrjohnson asystemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT prashantksrivastava systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT jonathanvaneyll systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT patricegodard systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT manuelamazzuferi systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT andreedelahayeduriez systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT juliettevansteenwinckel systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT pierregressens systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT benedictedanis systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT catherinevandenplas systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT patrikfoerch systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT karineleclercq systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT georgesmairetcoello systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT alvarocardenas systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT fredericvanclef systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT liisilaaniste systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT isabelleniespodziany systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT jameskeaney systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT juliengasser systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT gaellegillet systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT kirillshkura systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT seonahchong systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT jacquesbehmoaras systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT irenakadiu systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT enricopetretto systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT rafalmkaminski systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
AT michaelrjohnson systemslevelframeworkfordrugdiscoveryidentifiescsf1rasanantiepilepticdrugtarget
_version_ 1718380697574440960